[A new method for the comparative quantitative assessment of a radiomodifying effect].
Boĭko. V N VN; Zholus. R B RB; Legeza. V I VI
Key Findings
- A new integral index of protection is proposed for evaluating radioprotectors.
- Thymogen is listed among several agents evaluated with this new method.
- The new index is argued to be more informative than the traditional dose‑reduction factor.
Practical Outcomes
- The study mainly offers a new measurement tool rather than direct guidance on using thymogen. Biohackers may note that thymogen shows some radioprotective activity, but no specific dosage or protocol is provided, so further research is needed before practical application.
Summary
The paper introduces a new way to measure how well substances protect against radiation damage, using an overall protection index instead of the older dose‑reduction factor. It tests several compounds, including thymogen, to see how effective they are, but it doesn’t give dosing or practical usage tips.
Abstract
A new criterion for the quantitative estimation of a radioprotective effect (radioprotector efficiency) is suggested. This is an integral index of protection. Biologically, this is an estimation of a proportion of animals survived, the survival rate in the experimental and control groups of exposed objects in the studied dose range. The methods of assessing the criterion, and its advantages over the commonly used dose reduction factor (DRF) are described. The efficiency of Cystamine, Naphthysin, Indralin, Thymogen, Lymphokinin, Prodigiosan, and Polyribonate are considered using the suggested criterion. A new method of a comparative estimation of the radioprotective effect is suggested.
Study Information
pubmed
1997